What's new

Human medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 17, Status: Authorised

May 27, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Galafold, migalastat, Date of authorisation: 25/05/2016, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Xenpozyme, olipudase a...

Next Article

Human medicines European public assessment report (EPAR): Icandra (previously Vi...

Related Posts

Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

European Shortages Monitoring Platform (ESMP) User guid...

May 13, 2025  0

EMEA-003130-PIP02-23

EMEA-003130-PIP02-23

May 12, 2025  0